SCHEMBL3040219

SCHEMBL3040219

CC(C)(C)OC(=O)n1c(-c2ccc(OS(=O)(=O)c3c(Cl)cccc3Cl)c3c2C(=O)NC3)cc2cc(CN3CCCCC3)ccc21

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 16/20 0.34
BRD4 O60885 1/20 0.33
CREBBP Q92793 1/20 0.33
NR1H3 Q13133 4/20 0.32
HTR6 P50406 2/20 0.32
STS P08842 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3047986 0.93 HTR6 (0.37) NR1H2BRD4CREBBPNR1H3HTR6
SCHEMBL3047031 0.93 NR1H2 (0.39) NR1H2BRD4CREBBPNR1H3
SCHEMBL3046639 0.93 NR1H2 (0.35) NR1H2BRD4CREBBPNR1H3HTR6
SCHEMBL3049978 0.91 NR1H2 (0.39) NR1H2BRD4CREBBPNR1H3STS
SCHEMBL3048077 0.91 NR1H2 (0.34) NR1H2NR1H3
SCHEMBL3042102 0.90 LMNA (0.34) NR1H2
SCHEMBL3043784 0.90 BDKRB1 (0.34) NR1H2BRD4CREBBP
SCHEMBL3044012 0.90 NR1H2 (0.37) NR1H2HTR6
SCHEMBL3039560 0.90 NR1H2 (0.40) NR1H2NR1H3
SCHEMBL3047662 0.90 NR1H2 (0.37) NR1H2BRD4CREBBPNR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 NR1H2 21/4885BRD4 47/4885CREBBP 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.